3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Thoracic
10
Genitourinary
10
CNS
9
Gastrointestinal
8
Breast
7
Sarcoma
6
Gynecologic
3
Lymphoid
2
Plasma cell
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Endocrine
1
Classical hematology
1
Conditions
Neuroendocrine Tumors
130
Pituitary Neoplasms
72
Thyroid Cancer, Papillary
59
Pheochromocytoma
54
Multiple Endocrine Neoplasia Type 1
31
Thyroid Neoplasms
30
Paraganglioma
28
Adrenal Gland Neoplasms
27
Neoplasms
26
Pancreatic Neoplasms
21
Carcinoid Tumor
20
Adrenocortical Carcinoma
19
Hyperaldosteronism
17
Cushing Syndrome
17
Carcinoma, Neuroendocrine
17
Gastro-enteropancreatic neuroendocrine tumor
16
Acromegaly
15
Pituitary Diseases
14
Lung Neoplasms
13
Stomach Neoplasms
11
Prostatic Neoplasms
11
Neoplasm Metastasis
11
Carcinoma, Hepatocellular
11
Breast Neoplasms
11
Multiple Endocrine Neoplasia
10
Melanoma
10
Thyroid Carcinoma, Anaplastic
9
Prolactinoma
9
Lymphatic Metastasis
9
Insulinoma
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Disease Progression
×
Endocrine
×
Clear all
NCT02270567
2025-11-13
RegisterNET
Wren Laboratories LLC
Enrolling by invitation
400 enrolled